Some studies show no significantly higher concentration of serum leptin in prostate cancer, compared to healthy patients or patients with benign prostate hyperplasia [54], or in prostate tumor patients [55], while others show its concentration to be higher [52, 56]. This evidence concerns the gene LEP and benign prostatic hyperplasia.